Lucien Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 07-12-2024
- Company Age 2 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 Cr
as on 07-12-2024
About Lucien Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹4.50 Cr.
Sankaralingam Arunkumar, Mambalam Govindarajulu, Ramidi Manu, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24299TG2022PTC169112
- Company No.
169112
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2022
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lucien Life Sciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sankaralingam Arunkumar  | Director | 12-Dec-2022 | Current |
| Mambalam Govindarajulu | Director | 12-Dec-2022 | Current |
| Ramidi Manu | Director | 12-Dec-2022 | Current |
| Stephen Kumar | Director | 12-Dec-2022 | Current |
| Vrinda Kacham | Director | 12-Dec-2022 | Current |
| Vineel Kacham | Director | 12-Dec-2022 | Current |
Financial Performance of Lucien Life Sciences.
Lucien Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lucien Life Sciences?
Unlock access to Lucien Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Icon Formulations Private LimitedActive 11 years 7 monthsSankaralingam Arunkumar, Mambalam Govindarajulu and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 Aug 2023 | ₹4.50 Cr | Open |
How Many Employees Work at Lucien Life Sciences?
Lucien Life Sciences has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucien Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucien Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
